CN113827634B - 一种防治鱼鳞病蛇皮病的中药组合物及其制备方法和应用 - Google Patents
一种防治鱼鳞病蛇皮病的中药组合物及其制备方法和应用 Download PDFInfo
- Publication number
- CN113827634B CN113827634B CN202111258299.7A CN202111258299A CN113827634B CN 113827634 B CN113827634 B CN 113827634B CN 202111258299 A CN202111258299 A CN 202111258299A CN 113827634 B CN113827634 B CN 113827634B
- Authority
- CN
- China
- Prior art keywords
- parts
- decocting
- traditional chinese
- preventing
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 74
- 239000000203 mixture Substances 0.000 title claims abstract description 50
- 206010021198 ichthyosis Diseases 0.000 title claims abstract description 31
- 230000003405 preventing effect Effects 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 201000010099 disease Diseases 0.000 title abstract description 22
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract description 22
- 238000002791 soaking Methods 0.000 claims abstract description 31
- 241000270295 Serpentes Species 0.000 claims abstract description 16
- 244000195896 dadap Species 0.000 claims abstract description 15
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 14
- 241000830536 Tripterygium wilfordii Species 0.000 claims abstract description 14
- 235000015398 thunder god vine Nutrition 0.000 claims abstract description 14
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 11
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 11
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 9
- 241000243684 Lumbricus Species 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 241000931705 Cicada Species 0.000 claims abstract description 3
- 240000007890 Leonurus cardiaca Species 0.000 claims abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 44
- 239000007788 liquid Substances 0.000 claims description 37
- 238000001914 filtration Methods 0.000 claims description 27
- 238000002156 mixing Methods 0.000 claims description 20
- 241000382455 Angelica sinensis Species 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 2
- 238000010304 firing Methods 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims description 2
- 229940126680 traditional chinese medicines Drugs 0.000 claims description 2
- 241000112528 Ligusticum striatum Species 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 47
- 230000000694 effects Effects 0.000 abstract description 21
- 241000244365 Ligusticum sinense Species 0.000 abstract description 13
- 241001180876 Saposhnikovia Species 0.000 abstract description 10
- 238000000034 method Methods 0.000 abstract description 9
- 235000012907 honey Nutrition 0.000 abstract description 8
- 229940079593 drug Drugs 0.000 abstract description 7
- 230000006870 function Effects 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 230000004060 metabolic process Effects 0.000 abstract description 2
- 238000003860 storage Methods 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 238000009835 boiling Methods 0.000 description 18
- 208000002193 Pain Diseases 0.000 description 17
- 241000207925 Leonurus Species 0.000 description 12
- 230000000144 pharmacologic effect Effects 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 239000012530 fluid Substances 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 11
- 206010010904 Convulsion Diseases 0.000 description 9
- 230000036461 convulsion Effects 0.000 description 9
- 239000002674 ointment Substances 0.000 description 8
- 208000003251 Pruritus Diseases 0.000 description 7
- 241000125175 Angelica Species 0.000 description 6
- 235000001287 Guettarda speciosa Nutrition 0.000 description 6
- 241000361919 Metaphire sieboldi Species 0.000 description 6
- 238000004806 packaging method and process Methods 0.000 description 6
- 238000007789 sealing Methods 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 238000003958 fumigation Methods 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- 230000008736 traumatic injury Effects 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 4
- 241000475481 Nebula Species 0.000 description 4
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 239000012467 final product Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 238000010298 pulverizing process Methods 0.000 description 4
- 230000002936 tranquilizing effect Effects 0.000 description 4
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 230000006793 arrhythmia Effects 0.000 description 3
- 206010003119 arrhythmia Diseases 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 230000004089 microcirculation Effects 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 208000031225 myocardial ischemia Diseases 0.000 description 3
- 201000009240 nasopharyngitis Diseases 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 208000017520 skin disease Diseases 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- 206010020741 Hyperpyrexia Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010024229 Leprosy Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 206010043376 Tetanus Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 229930002330 retinoic acid Natural products 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 229960001727 tretinoin Drugs 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 241000132011 Atractylodes lancea Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 241001517488 Clavus Species 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000004929 Facial Paralysis Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 208000032382 Ischaemic stroke Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 206010024769 Local reaction Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010061876 Obstruction Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010039710 Scleroderma Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000003509 anti-fertility effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000000731 choleretic agent Substances 0.000 description 1
- 230000001989 choleretic effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000002920 convulsive effect Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000000369 enteropathogenic effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 210000001034 respiratory center Anatomy 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Insects & Arthropods (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Animal Husbandry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种防治鱼鳞病蛇皮病的中药组合物及其制备方法和应用,具体涉及医药领域。所述中药组合物包括川穹,雷公藤,海桐皮,皂角刺,红花,益母草,当归,蝉蜕,蛇蜕,苍术,防风,艾叶和地龙。所述制备方法包括原料药粉碎,浸泡和煎药。所述应用包括药学常用剂型的制备和在防治鱼鳞蛇皮病上的应用。本发明提供的中药组合物用于治疗鱼鳞病蛇皮病疗效确切,具有软化鳞屑,加快皮肤排汗代谢功能,副作用小,治疗效果好,使用的重要原料容易获得,价格低。且制备本发明的中药组合物的方法简单,易于工业化大生产。本发明制备的膏剂因经浓缩并含有蜂蜜等辅料制备而成,具有浓度高,体积小,有良好的保存性,便于使用等优点。
Description
技术领域
本发明涉及医药领域,具体涉及一种防治鱼鳞病蛇皮病的中药组合物及其制备方法和应用。
背景技术
蛇皮病实际上就是我们通常所说的鱼鳞病。因为一般表现在双下肢,外观上类似于蛇皮一样,所以又把它称之为蛇皮病。这种情况一般大多是由于遗传因素导致,主要是表现为皮肤的过度角化,由于过度角化,所以造成局部的一些汗腺或者是皮脂腺分泌功能障碍,所以表现局部皮肤的粗糙等反应。
目前临床常用的治疗鱼鳞病蛇皮病的药物主要为尿素软霜、维A酸类软膏以及糖皮质激素软膏及换血疗法等进行治疗。但现有的药物在临床应用中很多病人只可缓解部分症状并不能达到较好的疗效,或者因为副作用无法坚持长期用药。此外,在发展中国家,一些有效的生物产品使用受限,以及部分价格较高等因素,限制了他们的广泛应用。
发明内容
为此,本发明提供一种防治鱼鳞病蛇皮病的中药组合物及其制备方法和应用,以解决现有治疗药物副作用大、治疗效果差,生物药物价格高等问题。
为了实现上述目的,本发明提供如下技术方案:
根据本发明的第一方面提供的一种防治鱼鳞病蛇皮病的中药组合物,所述中药组合物包括以下重量份的中药,川穹5-20份,雷公藤5-20份,海桐皮5-20份,皂角刺5-20份,红花5-20份,益母草5-20份,当归5-20份,蝉蜕5-20份,蛇蜕5-20份,苍术5-20份,防风5-20份,艾叶5-20份,地龙5-20份。
根据本发明的第二方面提供的一种防治鱼鳞病蛇皮病的中药组合物的制备方法,所述方法包括:
步骤一,按照重量分数称取各原料药,混合均匀后粉碎成粉末;
步骤二,将药物粉末装入无纺袋中,放入煎药锅中,加水浸泡,开火,大火煮20-30min,过滤取药液;
步骤三,煎药锅中再加适量水煎煮取药液,步骤二步骤三的药液混合后再次煎煮,过滤取药液,即得防治鱼鳞病蛇皮病的中药组合物。
进一步的,加水浸泡的时间为0.5-2h。
进一步的,所述步骤三中水煎煮的时间为20-30min;再次煎煮的时间为5-15min。
根据本发明的第三方面提供的一种防治鱼鳞病蛇皮病的中药组合物可添加药学常用辅料,制备成包括膏剂、洗剂的药物。
根据本发明的第四方面提供的一种防治鱼鳞病蛇皮病的中药组合物膏剂的制备方法,其特征在于,所述方法包括:
步骤一,按照重量分数称取各原料药,
先选:川穹5-20份,雷公藤5-20份,蛇蜕5-20份,苍术5-20份,海桐皮5-20份,加适量的水浸润药材,领其充分吸收,稍后再加水高出药材面10-20cm,浸泡12-48小时;
后选:皂角刺5-20份,红花5-20份,益母草5-20份,当归5-20份,防风5-20份,艾叶5-20份,地龙5-20份加水高出药材8-15cm,浸泡12-48小时;
步骤二,先选浸泡后药料加水先开火煎煮,先用大火煮沸,再用小火煮,最后转为微火煮,药汁渐浓,取纱布过滤头遍药汁,得先选药汁;后选浸泡后药料后开火煎煮,先用大火煮沸,转用小火保持沸腾煮;药汁渐浓,取纱布过滤头遍药汁,得后选药汁;
步骤三,将步骤二中纱布过滤后得先选药渣和后选药渣分别再加水浸润药渣后上火煎煮,煎法步骤二,分别二煎、三煎后提取药汁,所有药汁混合,静置沉淀,再次过滤药渣,得过滤净得药汁;
步骤四,过滤净的药汁再次大火煎熬,加速药汁变稠厚,再改用小火浓缩,期间不断搅拌,后熬制成膏状,取清膏;取中蜜加入清膏中,小火慢熬,不断搅拌,后装入无菌瓶密封保存,得防治鱼鳞病蛇皮病的中药组合物膏剂。
进一步的,所述步骤二中,小火煮的时间为2h;微火煮的时间为3h;小火保持沸腾煮的时间为2小时。
进一步的,所述步骤三中静置时间为1h。
所述中药组合物各组分的功效:
【川穹】:
功效主治:活血行气,祛风止痛,主治月经不调,痛经闭经,产后腹痛,胸胁疼痛,跌打肿痛,疮疡脓成不溃,头痛,风湿痹痛。
现代药理运用:有增加心肌收缩,增加冠状动脉流量,抗血栓,改善微循环,镇静,抗肿瘤,抗射线,抗菌,利尿,解痉等作用。
【雷公藤】:
功效主治:祛风湿,活血通络,消肿止痛,杀虫解毒,主治风湿顽痹,麻风,顽癣,湿疹疥疮,疔疮肿毒。
现代药理运用:有抗炎,镇痛,抗肿瘤,抗生育,抗凝血,抗菌,改善微循环等作用。
【海桐皮】:
功效主治:祛风除湿,通络止痛,杀虫止痒,主治风湿腿脚麻木,腿脚筋骨疼痛,跌打损伤,顽癣,湿疹,疥疮。
现代药理运用:有抗炎,镇痛,镇静,增强心肌收缩力,降血压,抗菌等作用。
【皂角刺】:
功效主治:去顽痰,通窍开闭,去风杀虫,主治顽痰阻,肺咳喘,痰多喉痹,痰盛,疮毒初起,脓成不溃,皮癣,麻风。
现代药理运用;有祛痰,抗菌,溶血,抗癌,增强免疫力,抑制呼吸中枢,痤疮等。
【红花】:
功效主治:活血通经,去瘀止痛,主治血瘀,闭经,痛经,产后,腹痛,中风,半身不遂,跌打损伤,鸡眼,斑疹,丹毒,目赤肿痛。
现在药理运用:有抗心肌缺血,降血压,抗凝血,降血脂,镇静,镇痛,扁平疣,黄褐斑,带状疱疹等。
【益母草】:
功效主治:活血祛瘀,利水消肿,清热解毒,血瘀痛经,闭经,经行不畅,水肿,小便不利,疮痈肿毒,跌打损伤。
现代药理运用:有抗早孕,强心,心肌缺血,抗心律失常,降血压,抗血栓,抑制红细胞聚集,改善肾功能,利尿,过敏性皮肤病等
【当归】:
功效主治:补血活血,调经止痛,润肠通便,主治血虚,面色无华,头晕心悸,血虚血瘀,月经不调,痛经,闭经。
现代药理运用:有抗血小板聚集,抗血栓,抗贫血,促进造血功能,降血脂,改善微循环,抗心肌缺血,抗心律失常,降血压,平喘,镇痛,抗炎,利胆,肠道便秘,跌打肿痛等。
【蝉蜕】:
功效主治:疏散风热,利咽开音,透疹,明目退翳,息风止痉。主治风热感冒,温病初起,咽痛音哑,麻疹不透,风疹瘙痒,目赤翳障,急慢惊风,破伤风证,小儿夜啼不安。
现代药理运用:有镇静,抗惊厥,解热镇痛,抑制免疫,抗过敏,有降低毛细血管通透性,减缓心率,对红细胞有一定的保护作用,风麻疹、皮肤瘙痒等。
【蛇蜕】:功效主治:祛风、定惊、解毒、退翳,主治小儿惊风、抽搐痉挛、翳障、喉痹、疔肿、皮肤瘙痒症。
现代药理运用:有抗炎,抗菌,抗病毒,腮腺炎,中耳炎,湿疹等。
【苍术】:功效主治:燥湿健脾,祛风散寒,明目。主治脘腹胀满,泄泻,水肿,脚气痿蹙,风湿痹痛,风寒感冒,夜盲,眼目昏涩。
现代药理运用:抗胃炎、抗胃溃疡;调节胃肠运动;抗肝损伤;抗缺氧;对烟碱受体有阻断作用,护肝利胆,抗缺氧等。
【防风】:功效主治:祛风解表,胜湿止痛,止痉,止屑,止痒,主治感冒头痛,破伤风,腹痛,泄泻,肠风下血,小儿高热惊风。
现代药理运用:解热,镇痛,抗炎,抗过敏,抗菌,抗病毒,调节免疫功能,抗惊厥,抗凝血,抗肿瘤,促进小肠蠕动,风湿关节炎,皮肤病,面瘫等。
【艾叶】:
功效主治:温经止痛,散寒止痛,调经安胎,祛湿止痒。主治吐血,月经过多,崩漏,脘腹冷痛,宫冷不孕,外用治湿疹瘙痒等。
现代药理运用:有止血,平喘,镇咳,祛痰,镇惊,护肝利胆,抗过敏,抗菌,抗病毒,抗肿瘤,抑制心脏,溃疡性结肠炎,骨关节炎等
【地龙】:功效主治:清热,定惊,通络,平喘、利尿的功效。主治高热神昏,惊痫抽搐,关节痹痛,肺热喘咳,尿少水肿,高血压等症。
现代药理运用:有溶栓和抗凝作用,抗心律失常,降血压,缺血性脑卒中,抗癌,过敏性哮喘,硬皮病。
本发明具有如下优点:
本发明提供的中药组合物用于治疗鱼鳞病蛇皮病疗效确切,具有软化鳞屑,加快皮肤排汗代谢功能,副作用小,治疗效果好,使用的重要原料容易获得,价格低。且制备本发明的中药组合物的方法简单,易于工业化大生产。
本发明制备的膏剂因经浓缩并含有蜂蜜等辅料制备而成,具有浓度高,体积小,有良好的保存性,便于使用等优点。
附图说明
为了更清楚地说明本发明的实施方式或现有技术中的技术方案,下面将对实施方式或现有技术描述中所需要使用的附图作简单地介绍。显而易见地,下面描述中的附图仅仅是示例性的,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据提供的附图引伸获得其它的实施附图。
本说明书所绘示的结构、比例、大小等,均仅用以配合说明书所揭示的内容,以供熟悉此技术的人士了解与阅读,并非用以限定本发明可实施的限定条件,故不具技术上的实质意义,任何结构的修饰、比例关系的改变或大小的调整,在不影响本发明所能产生的功效及所能达成的目的下,均应仍落在本发明所揭示的技术内容得能涵盖的范围内。
图1为本发明提供的一种实施例3制备的膏剂治疗前后对比图,其中,A为治疗前,B为治疗后;
图2为本发明提供的一种实施例4制备的膏剂治疗前后对比图,其中,A为治疗前,B为治疗后。
具体实施方式
以下由特定的具体实施例说明本发明的实施方式,熟悉此技术的人士可由本说明书所揭露的内容轻易地了解本发明的其他优点及功效,显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1一种防治鱼鳞病蛇皮病的中药组合物及其制备方法和应用
所述中药组合物包括以下重量份的中药,川穹5份,雷公藤10份,海桐皮5份,皂角刺15份,红花5份,益母草5份,当归5份,蝉蜕5份,蛇蜕10份,苍术5份,防风5份,艾叶5份,地龙5份。
制备中药组合物的方法包括:取中药组合物共混微粉碎装入无纺布袋,煎药锅中加适量水浸泡1小时,大火煮沸,转小火煮30分钟左右,过滤取药液备用,煎药锅中再加适量水煎煮30分钟左右取药液,一煎二煎药液混合后再次煎煮10分钟,过滤取药液即得中药组合物。
幼儿患者可直接取药液用于药浴,成人可直接取药液用于熏蒸,只腿部有症状患者可直接用足盆浸泡。
上述中药组合物的膏剂制备方法:
先选:川穹5份,雷公藤10份,蛇蜕10份,苍术5份,海桐皮5份,加适量的水浸润药材,领其充分吸收,稍后再加水高出药材面15cm左右,浸泡24小时。
后选;皂角刺15份,红花5份,益母草5份,当归5份,防风5份,艾叶5份,地龙5份加水高出药材10cm,浸泡24小时。
先选浸泡后药料先开火煎煮,先用大火煮沸,再用小火煮1小时,转为微火煮3小时,药汁渐浓,后选浸泡后药料后开火煎煮,先用大火煮沸,转用小火保持沸腾煮2小时。药汁渐浓,后分别取纱布过滤头遍药汁,分别再加水浸润药渣后上火煎煮,煎法同上,分别二煎、三煎后最取药汁,所有药汁混合,静置1小时沉淀,再次过滤药渣。
过滤净的药汁再次大火煎熬,加速药汁变稠厚,再改用小火浓缩,期间不断搅拌,后熬制成膏状,取清膏。
取中蜜加入清膏中,小火慢熬,不断搅拌,后装入无菌瓶密封保存。
实施例2一种防治鱼鳞病蛇皮病的中药组合物及其制备方法和应用
所述中药组合物包括以下重量份的中药,川穹10份,雷公藤15份,海桐皮20份,皂角刺5份,红花15份,益母草5份,当归5份,蝉蜕5份,蛇蜕5份,苍术10份,防风15份,艾叶5份,地龙5份。
制备中药组合物的方法包括:取中药组合物共混微粉碎装入无纺布袋,煎药锅中加适量水浸泡1小时,大火煮沸,转小火煮30分钟左右,过滤取药液备用,煎药锅中再加适量水煎煮30分钟左右取药液,一煎二煎药液混合后再次煎煮10分钟,过滤取药液即得中药组合物。
幼儿患者可直接取药液用于药浴,成人可直接取药液用于熏蒸,只腿部有症状患者可直接用足盆浸泡。
上述中药组合物的膏剂制备方法:
先选:川穹10份,雷公藤15份,蛇蜕5份,苍术10份,海桐皮20份,加适量的水浸润药材,领其充分吸收,稍后再加水高出药材面15cm左右,浸泡24小时。
后选;皂角刺5份,红花15份,益母草5份,当归5份,防风15份,艾叶5份,地龙5份加水高出药材10cm,浸泡24小时。
先选浸泡后药料先开火煎煮,先用大火煮沸,再用小火煮1小时,转为微火煮3小时,药汁渐浓,后选浸泡后药料后开火煎煮,先用大火煮沸,转用小火保持沸腾煮2小时。药汁渐浓,后分别取纱布过滤头遍药汁,分别再加水浸润药渣后上火煎煮,煎法同上,分别二煎、三煎后最取药汁,所有药汁混合,静置1小时沉淀,再次过滤药渣。
过滤净的药汁再次大火煎熬,加速药汁变稠厚,再改用小火浓缩,期间不断搅拌,后熬制成膏状,取清膏。
取中蜜加入清膏中,小火慢熬,不断搅拌,后装入无菌瓶密封保存。
实施例3一种防治鱼鳞病蛇皮病的中药组合物及其制备方法和应用
所述中药组合物包括以下重量份的中药,川穹20份,雷公藤5份,海桐皮10份,皂角刺20份,红花20份,益母草15份,当归15份,蝉蜕10份,蛇蜕15份,苍术20份,防风10份,艾叶10份,地龙15份。
制备中药组合物的方法包括:取中药组合物共混微粉碎装入无纺布袋,煎药锅中加适量水浸泡1小时,大火煮沸,转小火煮30分钟左右,过滤取药液备用,煎药锅中再加适量水煎煮30分钟左右取药液,一煎二煎药液混合后再次煎煮10分钟,过滤取药液即得中药组合物。
幼儿患者可直接取药液用于药浴,成人可直接取药液用于熏蒸,只腿部有症状患者可直接用足盆浸泡。
上述中药组合物的膏剂制备方法:
先选:川穹20份,雷公藤5份,蛇蜕15份,苍术20份,海桐皮10份,加适量的水浸润药材,领其充分吸收,稍后再加水高出药材面15cm左右,浸泡24小时。
后选;皂角刺20份,红花20份,益母草15份,当归15份,防风10份,艾叶10份,地龙15份加水高出药材10cm,浸泡24小时。
先选浸泡后药料先开火煎煮,先用大火煮沸,再用小火煮1小时,转为微火煮3小时,药汁渐浓,后选浸泡后药料后开火煎煮,先用大火煮沸,转用小火保持沸腾煮2小时。药汁渐浓,后分别取纱布过滤头遍药汁,分别再加水浸润药渣后上火煎煮,煎法同上,分别二煎、三煎后最取药汁,所有药汁混合,静置1小时沉淀,再次过滤药渣。
过滤净的药汁再次大火煎熬,加速药汁变稠厚,再改用小火浓缩,期间不断搅拌,后熬制成膏状,取清膏。
取中蜜加入清膏中,小火慢熬,不断搅拌,后装入无菌瓶密封保存。
实施例4一种防治鱼鳞病蛇皮病的中药组合物及其制备方法和应用
所述中药组合物包括以下重量份的中药,川穹15份,雷公藤20份,海桐皮15份,皂角刺10份,红花10份,益母草20份,当归20份,蝉蜕15份,蛇蜕20份,苍术15份,防风20份,艾叶15份,地龙20份。
制备中药组合物的方法包括:取中药组合物共混微粉碎装入无纺布袋,煎药锅中加适量水浸泡1小时,大火煮沸,转小火煮30分钟左右,过滤取药液备用,煎药锅中再加适量水煎煮30分钟左右取药液,一煎二煎药液混合后再次煎煮10分钟,过滤取药液即得中药组合物。
幼儿患者可直接取药液用于药浴,成人可直接取药液用于熏蒸,只腿部有症状患者可直接用足盆浸泡。
上述中药组合物的膏剂制备方法:
先选:川穹15份,雷公藤20份,蛇蜕20份,苍术15份,海桐皮15份,加适量的水浸润药材,领其充分吸收,稍后再加水高出药材面15cm左右,浸泡24小时。
后选;皂角刺10份,红花10份,益母草20份,当归20份,防风20份,艾叶15份,地龙20份加水高出药材10cm,浸泡24小时。
先选浸泡后药料先开火煎煮,先用大火煮沸,再用小火煮1小时,转为微火煮3小时,药汁渐浓,后选浸泡后药料后开火煎煮,先用大火煮沸,转用小火保持沸腾煮2小时。药汁渐浓,后分别取纱布过滤头遍药汁,分别再加水浸润药渣后上火煎煮,煎法同上,分别二煎、三煎后最取药汁,所有药汁混合,静置1小时沉淀,再次过滤药渣。
过滤净的药汁再次大火煎熬,加速药汁变稠厚,再改用小火浓缩,期间不断搅拌,后熬制成膏状,取清膏。
取中蜜加入清膏中,小火慢熬,不断搅拌,后装入无菌瓶密封保存。
实施例5一种防治鱼鳞病蛇皮病的中药组合物及其制备方法和应用
所述中药组合物包括以下重量份的中药,川穹20份,雷公藤5份,海桐皮15份,皂角刺5份,红花15份,益母草10份,当归10份,蝉蜕15份,蛇蜕5份,苍术10份,防风15份,艾叶10份,地龙15份。
制备中药组合物的方法包括:取中药组合物共混微粉碎装入无纺布袋,煎药锅中加适量水浸泡1小时,大火煮沸,转小火煮30分钟左右,过滤取药液备用,煎药锅中再加适量水煎煮30分钟左右取药液,一煎二煎药液混合后再次煎煮10分钟,过滤取药液即得中药组合物。
幼儿患者可直接取药液用于药浴,成人可直接取药液用于熏蒸,只腿部有症状患者可直接用足盆浸泡。
上述中药组合物的膏剂制备方法:
先选:川穹20份,雷公藤5份,蛇蜕5份,苍术10份,海桐皮15份,加适量的水浸润药材,领其充分吸收,稍后再加水高出药材面15cm左右,浸泡24小时。
后选;皂角刺5份,红花15份,益母草10份,当归10份,防风15份,艾叶10份,地龙15份加水高出药材10cm,浸泡24小时。
先选浸泡后药料先开火煎煮,先用大火煮沸,再用小火煮1小时,转为微火煮3小时,药汁渐浓,后选浸泡后药料后开火煎煮,先用大火煮沸,转用小火保持沸腾煮2小时。药汁渐浓,后分别取纱布过滤头遍药汁,分别再加水浸润药渣后上火煎煮,煎法同上,分别二煎、三煎后最取药汁,所有药汁混合,静置1小时沉淀,再次过滤药渣。
过滤净的药汁再次大火煎熬,加速药汁变稠厚,再改用小火浓缩,期间不断搅拌,后熬制成膏状,取清膏。
取中蜜加入清膏中,小火慢熬,不断搅拌,后装入无菌瓶密封保存。
测试例1
选取确诊的鱼鳞蛇皮病患者100例,年龄20-40岁,随机分成两组,各50例,对照组采用维A酸乳膏治疗,实验组采用本发明实施例3制备的膏剂,实验结果见表1所示。
判断指标:
治愈,鱼鳞蛇皮病患者治愈,与正常皮肤无差别
有效,鱼鳞蛇皮病患者有所改善
无效,涂抹后无任何效果
表1本发明膏剂与维A酸乳膏对鱼鳞蛇皮病患者治疗结果
治愈 | 有效 | 无效 | |
对照组 | 35 | 14 | 1 |
实验组 | 45 | 5 | 0 |
由表1可见,本发明制备的膏剂对鱼鳞蛇皮病患者有效率达100%,治愈可达90%,不比现在常用的维A酸乳膏的效果差,甚至于效果更佳。本发明实施例3膏剂治愈后治疗前后对比图见图1所示。
测试例2
选取患病婴幼儿0-10岁30例,给与本发明实施例4制备的膏剂进行治疗,其中治愈的数量占27例,有效的有3例,治愈的人数占总人数的90%。治疗前后对比图见图2所示,图2为有效的图片。
虽然,上文中已经用一般性说明及具体实施例对本发明作了详尽的描述,但在本发明基础上,可以对之作一些修改或改进,这对本领域技术人员而言是显而易见的。因此,在不偏离本发明精神的基础上所做的这些修改或改进,均属于本发明要求保护的范围。
Claims (5)
1.一种防治鱼鳞病的中药组合物,其特征在于,所述中药组合物由以下份数中药制成:川芎5-20份,雷公藤5-20份,海桐皮5-20份,皂角刺5-20份,红花5-20份,益母草5-20份,当归5-20份,蝉蜕5-20份,蛇蜕5-20份,苍术5-20份,防风5-20份,艾叶5-20份,地龙5-20份。
2.权利要求1所述一种防治鱼鳞病的中药组合物的制备方法,其特征在于,所述方法包括:
步骤一,按照重量分数称取各原料药,混合均匀后粉碎成粉末;
步骤二,将药物粉末装入无纺袋中,放入煎药锅中,加水浸泡,开火,大火煮20-30min,过滤取药液;
步骤三,煎药锅中再加适量水煎煮取药液,步骤二步骤三的药液混合后再次煎煮,过滤取药液,即得防治鱼鳞病的中药组合物。
3.根据权利要求2所述一种防治鱼鳞病的中药组合物的制备方法,其特征在于,加水浸泡的时间为0.5-2h。
4.根据权利要求2所述一种防治鱼鳞病的中药组合物的制备方法,其特征在于,所述步骤三中水煎煮的时间为20-30min;再次煎煮的时间为5-15min。
5.根据权利要求1所述防治鱼鳞病的中药组合物,其特征在于,添加药学常用辅料,制备成包括膏剂、洗剂的药物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111258299.7A CN113827634B (zh) | 2021-10-27 | 2021-10-27 | 一种防治鱼鳞病蛇皮病的中药组合物及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111258299.7A CN113827634B (zh) | 2021-10-27 | 2021-10-27 | 一种防治鱼鳞病蛇皮病的中药组合物及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113827634A CN113827634A (zh) | 2021-12-24 |
CN113827634B true CN113827634B (zh) | 2022-09-16 |
Family
ID=78966174
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111258299.7A Active CN113827634B (zh) | 2021-10-27 | 2021-10-27 | 一种防治鱼鳞病蛇皮病的中药组合物及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113827634B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101366856A (zh) * | 2008-10-17 | 2009-02-18 | 大连美罗中药厂有限公司 | 一种治疗鱼鳞病的中药组合物的质量控制方法 |
CN109908293A (zh) * | 2019-03-18 | 2019-06-21 | 北京美肤鱼鳞病研究院 | 一种熏蒸治疗鱼鳞病的中药组合物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106309698A (zh) * | 2016-09-27 | 2017-01-11 | 四川聚豪生物科技有限公司 | 一种治疗鱼鳞病的中药组合物及其制备方法 |
-
2021
- 2021-10-27 CN CN202111258299.7A patent/CN113827634B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101366856A (zh) * | 2008-10-17 | 2009-02-18 | 大连美罗中药厂有限公司 | 一种治疗鱼鳞病的中药组合物的质量控制方法 |
CN109908293A (zh) * | 2019-03-18 | 2019-06-21 | 北京美肤鱼鳞病研究院 | 一种熏蒸治疗鱼鳞病的中药组合物 |
Non-Patent Citations (1)
Title |
---|
当归饮在皮肤科中的应用;孙步云;《辽宁中医杂志》;19871231(第01期);23-24 * |
Also Published As
Publication number | Publication date |
---|---|
CN113827634A (zh) | 2021-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1164308C (zh) | 一种治疗骨科疾病的中药制剂 | |
CN102293947A (zh) | 一种治疗高血压的中药 | |
CN102078555B (zh) | 治疗偏头痛的中药 | |
CN102949624B (zh) | 一种中草药保健洗液及其制备方法 | |
CN102631413A (zh) | 一种治疗痤疮的中药组合物 | |
CN106309611A (zh) | 一种通筋活血膏药 | |
CN102078569B (zh) | 一种治疗肝癌的中药制剂及其制备方法 | |
CN102526502A (zh) | 一种治疗重症肌无力的中药制剂 | |
CN104547036A (zh) | 一种治疗风湿病的药酒 | |
CN101804110B (zh) | 一种抗血栓和降血脂的中药制剂 | |
CN103638190B (zh) | 治疗急性胆囊炎的中药 | |
CN101391065B (zh) | 一种用于治疗急慢性盆腔炎的木鳖子花椒汤 | |
CN113827634B (zh) | 一种防治鱼鳞病蛇皮病的中药组合物及其制备方法和应用 | |
CN102805800B (zh) | 一种治疗神经性皮炎的中药组合物 | |
CN105560531A (zh) | 治疗小儿湿疹的中药组合物及其制备方法 | |
CN104474108A (zh) | 一种治疗急性阑尾炎的中药制剂及制备方法 | |
CN101129512A (zh) | 泽归口服液 | |
CN102397322A (zh) | 一种治疗传染性肝炎的药物 | |
CN112691157A (zh) | 一种风湿类关节炎药材组合物的配方及制备方法 | |
CN105031595A (zh) | 一种治疗钱币状湿疹的中药片剂及其制备方法 | |
CN104338052A (zh) | 治疗脑血栓的中药配方 | |
CN102940806B (zh) | 一种治疗高血脂的中药组合物 | |
CN104606406B (zh) | 一种外用预防变应性鼻炎的中药膏及其制备方法 | |
CN102526544B (zh) | 一种治疗腰椎间盘突出及骨质增生的口服散剂中药 | |
CN104587078A (zh) | 一种治疗病毒性咽炎的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |